CIK 0001176309
- Non-accelerated filer
- Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980376008
- Phone
- +1 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Kidron Miriam Chief Scientific Officer | Grant or award | +357,000 | 1,907,554 | ||
| 2026-11-12 | Kidron Miriam Chief Scientific Officer | Grant or award | +242,000 | 2,149,554 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Grant or award | +208,125 | 1,341,263 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Grant or award | +209,291 | 1,550,554 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −104,000 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −100,000 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −69,999 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −47,000 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −100,000 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −72,000 | 0 | ||
| 2026-03-30 | Kidron Miriam Chief Scientific Officer | Shares withheld for taxes | −435,084 | $3.31 | $1.4M | 1,133,138 |
| 2026-03-17 | Kidron Miriam Chief Scientific Officer | Grant or award | +119,558 | 1,568,222 | ||
| 2026-01-22 | Kidron Miriam Chief Scientific Officer | Option exercise | +19,000 | 1,448,664 | ||
| 2026-01-22 | Kidron Miriam Chief Scientific Officer | Option exercise · Performance Stock Units | −19,000 | 0 | ||
| 2026-01-14 | Kidron Miriam Chief Scientific Officer | Gift | −86,166 | 1,343,498 | ||
| 2025-12-31 | Kidron Miriam Chief Scientific Officer | Grant or award | +121,331 | 1,314,664 | ||
| 2025-12-31 | Kidron Miriam Chief Scientific Officer | Grant or award | +115,000 | 1,429,664 | ||
| 2025-12-31 | Kidron Miriam Chief Scientific Officer | Grant or award · Performance Stock Units | +19,000 | 19,000 | ||
| 2025-02-11 | Kidron Miriam Chief Scientific Officer | Grant or award | +74,000 | 1,074,666 | ||
| 2025-02-11 | Kidron Miriam Chief Scientific Officer | Grant or award | +52,000 | 1,126,666 |
Page 1 of 3 · 46 trades